These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21105780)

  • 21. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
    J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
    Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.
    Kottilil S; Gamberg J; Bowmer I; Trahey J; Howley C; Gallant M; Grant M
    J Clin Immunol; 2000 May; 20(3):175-86. PubMed ID: 10941825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
    Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
    Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.
    Gamadia LE; Remmerswaal EB; Weel JF; Bemelman F; van Lier RA; Ten Berge IJ
    Blood; 2003 Apr; 101(7):2686-92. PubMed ID: 12411292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4(+) T helper cells and the role they play in viral control.
    Norris PJ; Rosenberg ES
    J Mol Med (Berl); 2002 Jul; 80(7):397-405. PubMed ID: 12110945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of CD4 and CD8 T cells in viral infections.
    Koszinowski UH; Reddehase MJ; Jonjic S
    Curr Opin Immunol; 1991 Aug; 3(4):471-5. PubMed ID: 1684507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression.
    Dalod M; Fiorentino S; Delamare C; Rouzioux C; Sicard D; Guillet JG; Gomard E
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):497-506. PubMed ID: 8679305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy.
    Poccia F; Agrati C; Martini F; Mejia G; Wallace M; Malkovsky M
    Immunol Lett; 2005 Aug; 100(1):14-20. PubMed ID: 16115692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8+ regulatory T cells in persistent human viral infections.
    Billerbeck E; Thimme R
    Hum Immunol; 2008 Nov; 69(11):771-5. PubMed ID: 18789990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of T-cell subsets in bacterial infections.
    Kaufmann SH
    Curr Opin Immunol; 1991 Aug; 3(4):465-70. PubMed ID: 1684506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
    McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine.
    Stanhope PE; Clements ML; Siliciano RF
    J Infect Dis; 1993 Jul; 168(1):92-100. PubMed ID: 8099941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral reactivities of gammadelta T cells.
    Poccia F; Agrati C; Martini F; Capobianchi MR; Wallace M; Malkovsky M
    Microbes Infect; 2005 Mar; 7(3):518-28. PubMed ID: 15777667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4
    Heinimäki S; Malm M; Vesikari T; Blazevic V
    Antiviral Res; 2018 Sep; 157():1-8. PubMed ID: 29935205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of recipient cytolytic activity attenuates allograft vasculopathy.
    Skaro AI; Liwski RS; O'Neill J; Vessie EL; Zhou J; Hirsch GM; Lee TD
    Transpl Immunol; 2005 Mar; 14(1):27-35. PubMed ID: 15814279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.